ArticleFrontiers in pharmacology2026

Exploring the impact of GLP-1 analogues and DPP-4 inhibitors on cognitive decline in elderly patients with type 2 diabetes: a competing risks analysis from a real-world cohort.

Vera Battini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.